|
PsychoGenics is a preclinical CRO with the focus on CNS, pain and muscle disorders. PsychoGenics offers a wide range of standard and customized preclinical services and provides a full complement of partnered drug discovery capabilities in the areas of psychiatric, cognitive, neurodegenerative disorders, pain, inflammation and traumatic injury. PsychoGenics currently has drug discovery partnerships with major pharmaceutical companies, including Eli Lilly, Roche and Sunovion.
Services Available at PsychoGenics
- Over 80 optimized and validated behavioral tests
- Disease animal models (genetic, surgical and pharmacological)
- Customized breeding and phenotyping
- Unique high throughput behavioral platforms for
- determination of therapeutic indication
- gait analysis
- detailed phenotyping, including motor, social, circadian and cognitive evaluation
- Electrophysiology
- in vivo (single and multi-unit recordings in multiple brain regions, hippocampal LTP)
- in vitro (slice and cell recordings, drug screening: Dynaflow)
- coming soon: slice LTP and EEG
- Neurochemistry and Microdialysis in tissue (brain, skin, muscle), CSF, and blood
- Molecular and cell biology
- microwave technology to assess phosphoproteins and second messengers in vivo
- qWestern, qPCR and ELISA
- receptor autoradiography, in vivo/ex vivo receptor occupancy
- Neurogenesis
- Imaging services including fMRI and phMRI in conscious rodents and non-human primates, and CT imaging
New in 2012: Oncology (subcutaneous, intrasplenic and intrahepatic tumor xenograft models)
For more information please Contact us
|
No comments:
Post a Comment